Treatment of obesity type 1 diabetes with Dapagliflozin:a case report
10.3969/j.issn.1006-6187.2024.02.009
- VernacularTitle:达格列净治疗肥胖1型糖尿病一例报道
- Author:
Yao YAO
1
;
Wei YANG
;
Tao XUE
;
Xiaoou CHEN
;
Mingming TANG
;
Qiaoyun CHEN
;
Qianwei ZHANG
;
Lixia SUO
;
Lihua WANG
Author Information
1. 201800 上海健康医学院附属嘉定区中心医院内分泌
- Keywords:
Dapagliflozin;
Sodium-glucose co-transporter 2 inhibitor;
Obesity;
Diabetes mellitus,type 1
- From:
Chinese Journal of Diabetes
2024;32(2):133-136
- CountryChina
- Language:Chinese
-
Abstract:
As a new hypoglycemic drug,Dapagliflozin has attracted much attention because of its unique hypoglycemic mechanism. It has been used in many studies on type 2 diabetes mellitus,but the application of type 1 diabetes mellitus(T1DM)in the eastern population is rare. This article uses Dapagliflozin through a case of obese T1DM to provide new ideas for the treatment of T1DM.